Increase in the circulating level of hepatocyte growth factor in pancreatic cancer patients

Bratislava Medical Journal

Volumn 110, Issue 10, 2009, Pages 627-629

  Kemik, Ozgur ^a   Purisa, Sevim ^b   Kemik, Ahu Sarbay ^b   Tuzun, Sefa ^a  

^a Haseki Training Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Hepatocyte growth factor; Invasive; Pancreatic cancer

Indexed keywords

SCATTER FACTOR;

AGED; ARTICLE; BLOOD; FEMALE; HUMAN; MALE; MIDDLE AGED; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY;

AGED; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS;

EID: 75649114192     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. 1997 CA Cancer J Clin 1997; 47: 6-27.
2. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer 1995; 76: 1671-1677.
3. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 1996; 223: 273-279.
4. Yamamoto S, Tomita Y, Hoshida Y et al. Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. Clin Cancer Res 2004; 10: 2846-2850.
5. Singh-Kaw P, Zarnegar R, Siegfried JM. Stimulatory effects of hepatocyte growth factor on normal and neoplastic human epithelial cells. Amer J Physiol 1995; 268: L1012-1020.
6. Rosen EM, Knesel J, Goldberg ID, Jin L et al. Scatter factor mo dulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int J Cancer 1994; 57: 706-714.
7. Weidner KM, Behrens J, Vandekerckhove J et al. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 1990; 111: 2097-2108.
8. Montesan R, Matsumoto K, Nakamura T et al. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67: 901-908.
9. Grant DS, Kleinman HK, Goldberg ID et al. Scatter factor induces blood vessels f formation in vivo. Proc Natl Acad Sci USA 1993; 90: 1937-1941.
10. Igawa T, Kanda S, Kanetake H et al. Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochem Biophys Res Commun 1991; 174: 831-838.
11. Yamashita J, Ogawa M, Beppu T. Immunoreactive hepatocyte growth factor is present in tissue extracts from human breast cancer but not in conditioned medium of human breast cancer cell lines. Res Commun Chem Pathol Pharmacol 1993; 82: 249-252.
12. Siegfried JM, Weissfeld LA, Luketich JD et al. The clinical signi ficance of hepatocyte growth factor for non-small cell lung cancer. Ann Thorac Surg 1998; 66: 1915-1918.
13. Sobin LH, Wittekind CH. TNM classification of malignant tumors. 6th ed. New York (NY): Willey-Liss; 2002.
14. Shenn-Chen SM, Liu YW, Eng HL, Chou FF. Serum levels of Hepatocyte growth factor in patients with breast cancer. Cancer Epi Bio Prevent 2005; 14 (3): 715-717.
15. Jeffer M, Rong S, Anver M, Woude GFV. Autocrine hepatocyte growth factor/scatter factor-met signaling induces transformation and the invasive/metastatic phenotype in C127 cells. Oncogene 1996; 13: 853-861.
16. Bellusci S, Mones G, Gaudino G et al. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 1994; 9: 1091-1099.
17. Seslar SP, Nakamura T, Stephen WB. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors. Cancer Res 1993; 53: 1233-1238.
18. Tajima H, Matsumoto K, Nakamura T. Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines. FEBS Lett 1991; 291: 229-232.
19. Matsumoto K, Tajima H, Nakamura T. Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. Biochem Biophys Res Commun 1991; 176: 45-51.